Half-life is the time it takes for a quantity to fall to half its starting value. For a peptide, it usually describes how long the compound persists in a biological system before being broken down or removed. Because decay is exponential, the same fraction disappears in each equal slice of time: after one half-life about 50% remains, after two half-lives about 25%, and after three about 12.5%. That pattern is fixed, but the length of a single half-life is not — it depends on the molecule and on how it is measured. This article explains, at a high level, what pushes a peptide's half-life up or down, and why the number you read in one place may not match the number somewhere else.
Everything below is chemistry and measurement context for research and education. It is not dosing guidance, and no part of it suggests using any compound.
Amino acid sequence and structure
A peptide is a short chain of amino acids. The specific sequence — which residues appear and in what order — is the first thing that determines how quickly enzymes can recognise and cut the chain. The body is full of proteases, enzymes that cleave peptide bonds. Some sequences present many easy cut sites; others fold or arrange themselves so that those sites are harder to reach.
Several structural features tend to correlate with a longer or shorter measured half-life:
- Chain length. Very short peptides are often cleared quickly by the kidneys simply because small molecules filter out easily.
- Terminal residues. The exposed ends of a peptide (the N-terminus and C-terminus) are frequent targets for enzymes that trim chains from the ends inward.
- Secondary structure. A peptide that folds into a stable shape can shield its own cleavage sites, slowing enzymatic attack.
- Charge and solubility. How the molecule interacts with water and with proteins in solution influences how it distributes and how fast it is removed.
None of these act alone. Two peptides of the same length can have very different stabilities because one happens to place a vulnerable bond where an enzyme can reach it and the other does not.
Chemical modifications that extend persistence
Researchers frequently redesign peptides specifically to slow their breakdown. These modifications do not change what the peptide is described as doing — they change how long it survives before clearance. Common approaches discussed in the literature include:
- End-capping. Chemically blocking the N- or C-terminus (for example, by acetylation or amidation) makes the ends harder for trimming enzymes to grab.
- Non-natural amino acids. Swapping a standard residue for a mirror-image (D-form) or otherwise unusual amino acid can leave a bond that natural proteases do not cut efficiently.
- Cyclisation. Joining the ends into a ring removes the free termini that exopeptidases attack.
- Fatty-acid attachment (lipidation). Adding a lipid chain lets the peptide bind to large carrier proteins in the blood. Riding along with a big protein slows kidney filtration dramatically and can turn a half-life of minutes into one of hours or days.
- PEGylation. Attaching polyethylene glycol increases the molecule's effective size, again reducing how fast it filters out.
This is why a modified peptide and its unmodified parent sequence can sit at opposite ends of a half-life table even though they share a backbone. The modification is often the single biggest lever on the number.
Clearance: how the molecule leaves
Half-life is not only about how fast something is destroyed — it is also about how fast it is removed. Two broad routes dominate:
- Enzymatic degradation. Proteases cut the chain into fragments, which are then processed further. Sequences rich in easy cut sites clear faster.
- Physical elimination. Small, unbound molecules are filtered by the kidneys and leave the system. Larger molecules, or ones bound to carrier proteins, are filtered much more slowly.
Because these routes work together, a change that only affects one of them can still move the overall half-life a lot. A lipid tail, for instance, barely changes enzymatic vulnerability but hugely slows physical clearance — and the measured half-life follows the slower of the two processes.
Why published half-life figures disagree
If you compare several sources, you will often find different half-life values for what looks like the same peptide. This is normal, and it usually reflects measurement context rather than error. Some of the main reasons:
| Source of variation | Why it shifts the number |
|---|---|
| Model system | Values measured in a test tube, in different species, or in humans are not interchangeable. |
| What was measured | Some figures track the intact peptide; others track a metabolite or total activity, which decay at different rates. |
| Assay method | Different detection methods have different sensitivity and pick up different fractions of the molecule. |
| Distribution vs. elimination | A compound can show a fast early drop (spreading through the body) and a slower later decline (true elimination), producing two different "half-lives". |
| Exact molecule | Salt forms, modifications, or a slightly different sequence can be reported under the same common name. |
Because of this, a single half-life figure is best treated as an approximate anchor, not a precise constant. When you see a range, the range itself is the useful information.
Turning a half-life into a decay curve
Once you have a stated half-life from a reliable source, the exponential-decay pattern is fixed and easy to visualise. You can feed a half-life into our peptide half-life decay calculator to model how a stated amount falls over time, or browse reference values on the peptide half-life chart to compare compounds at a glance. The table below shows the fixed fractions that remain after each half-life, regardless of which peptide you are looking at:
| Half-lives elapsed | Approx. fraction remaining | |
|---|---|---|
| 0 | 100% | |
| 1 | 50% | |
| 2 | 25% | |
| 3 | ~12.5% | |
| 4 | ~6.25% | |
| 5 | ~3.13% |
Notice that the shape never changes — only the time axis stretches or compresses depending on the peptide's half-life. A compound with a half-life of one hour and one with a half-life of one week both follow this exact curve; the second simply takes 168 times as long to travel through it. If you want a walkthrough of reading these numbers in context, see how to read a peptide half-life.
A note on stability versus half-life
It is worth separating two ideas that sound similar. Biological half-life describes how long a peptide persists inside a living system. Storage stability describes how long a reconstituted peptide stays intact in a vial. They are different measurements with different drivers. Storage stability depends on temperature, light exposure, and the diluent used — reconstituted peptides are generally kept refrigerated and protected from light, though stability varies by compound. This is general handling information, not medical advice; always follow the material's certificate of analysis and stability data. Do not use a biological half-life figure to estimate how long a vial will keep, or vice versa.
Educational content only — not medical advice and not dosing guidance. Always verify against primary literature and your material's certificate of analysis.